🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesHOMA-IR tracking on GLP-1 — anyone have experience?

HOMA-IR tracking on GLP-1 — anyone have experience?

SandraNC_45 Wed, May 22, 2024 at 1:19 PM 11 replies 2,013 viewsPage 1 of 3
This thread is more than 22 months old. Information may be outdated. Consider searching for more recent discussions.
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
May 22, 2024 at 2:44 PM#1
Let's build a community tracker! Share your A1c journey on GLP-1 therapy. Format: - Medication & dose - Starting A1c - Current A1c - Time on medication - Type 2 or non-diabetic I'll start: Semaglutide 1.0 mg weekly | Timepoint | A1c | Notes | |-----------|-----|-------| | Baseline (Nov 2024) | 7.8% | Newly diagnosed T2D | | 3 months | 6.4% | Added metformin 500mg | | 6 months | 5.7% | Dropped metformin | | 9 months (now) | 5.4% | Diet + sema only | My endo literally said "you've achieved pharmacological remission." I cried in the office lol. No shame. 🥲
41 17FranDenver, Dr.BariatricHTX, LindaRN_retired and 38 others
Reply Quote Save Share Report
FitDadDave
Member
534
2,678
Jul 2024
Minneapolis, MN
May 22, 2024 at 3:01 PM#2
Love this thread. Here's mine: Tirzepatide 10 mg weekly | Timepoint | A1c | Fasting Glucose | |-----------|-----|----------------| | Baseline (Mar 2025) | 9.2% | 186 mg/dL | | 3 months | 6.8% | 118 mg/dL | | 5 months (now) | 6.1% | 102 mg/dL | T2D diagnosed 4 years ago. Was on metformin + glipizide. Dropped glipizide at month 3, may drop metformin soon. My doctor is cautiously optimistic. The 9.2 to 6.1 in 5 months blows my mind.
27 21kim_atl_prep, sarah_TO, wendy_avl and 24 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
May 22, 2024 at 3:18 PM#3
Not as dramatic but I'm happy with my progress: Semaglutide 0.5 mg weekly (can't tolerate higher doses) | Timepoint | A1c | |-----------|-----| | Baseline | 6.9% | | 3 months | 6.5% | | 6 months | 6.2% | | 9 months | 5.9% | | 12 months | 5.8% | Slow but consistent. My doctor says the trend matters more than the speed. I'll take it.
31 19jennifer_SEA, tyler_CSCS, VanRx_Mike and 28 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
May 22, 2024 at 3:35 PM#4
Okay so I'm a bit worried. I'm prediabetic (not T2D) and started Wegovy for weight loss. My A1c was 5.9% at baseline and after 4 months it's... still 5.9%. No change. My fasting glucose went from 108 to 96 though. Is the A1c supposed to drop faster? Am I a non-responder?
47 18NurseKim_ATL, paul_denver, TinaHashiRN and 44 others
Reply Quote Save Share Report
DadBodDave
Member
187
923
Nov 2024
Ohio
May 22, 2024 at 3:52 PM#5
> Is the A1c supposed to drop faster? Am I a non-responder? Carl, chill — you're fine 😄 A few things: 1. A1c reflects a 3-month average of blood sugar, weighted toward the most recent 30 days. At 4 months you're really only seeing ~1 month of true effect. 2. Your fasting glucose dropped 12 points — that IS working. 3. Going from 5.9% to 5.9% might mean you went from "high 5.9" to "low 5.9" — A1c resolution is only about 0.1%. 4. For prediabetics, the A1c changes are smaller in absolute terms because you're starting lower. Going from 5.9 to 5.5 is actually a bigger relative improvement than someone going from 9 to 7. Give it another 3 months. I bet you'll see 5.5-5.6% at your next draw.
Last edited: May 22, 2024 at 6:52 PM
18 10JakeBK_lifts, DerekSJ_a1c, paige_pharma and 15 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register